Clinical Trial Update: A Research Study to Look at How Faster Aspart Works in Chinese People With Type 1 Diabetes or Type 2 Diabetes [Phase 1]

View source ↗

Summary

A Phase 1 study assessing how faster-acting insulin aspart works in Chinese people with Type 1 or Type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Fiasp (insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED